Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Abstract Introduction Ritlecitinib demonstrated efficacy in patients with alopecia areata (AA) in the ALLEGRO phase 2b/3 study (NCT03732807). However, hair loss presentation may vary based on location (e.g., scalp, eyebrow/eyelash, body). Here, we sought to identify distinct hair loss profiles at ba...

Full description

Bibliographic Details
Main Authors: Diamant Thaçi, Christos Tziotzios, Taisuke Ito, Justin Ko, Ayşe Serap Karadağ, Hong Fang, Roger A. Edwards, Gianluca Bonfanti, Robert Wolk, Helen Tran, Ernest Law
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-09-01
Series:Dermatology and Therapy
Subjects:
Alopecia areata
Hair loss
Latent class analysis
Ritlecitinib
Online Access:https://doi.org/10.1007/s13555-023-00997-x

Internet

https://doi.org/10.1007/s13555-023-00997-x

Similar Items